Issue 3, 2018
From the journal:

MedChemComm

Correction: Novel valdecoxib derivatives by ruthenium(ii)-promoted 1,3-dipolar cycloaddition of nitrile oxides with alkynes – synthesis and COX-2 inhibition activity

Silvia Roscales,a   Nicole Bechmann,a   Daniel Holger Weiss,b   Martin Köckerling,b   Jens Pietzschac  and  Torsten Kniess*a  

* Corresponding authors

a Department of Radiopharmaceutical and Chemical Biology, Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Bautzner Landstraße 400, 01328 Dresden, Germany
E-mail: t.kniess@hzdr.de

b Department of Inorganic Solid State Chemistry, Institute of Chemistry, University of Rostock, Albert Einstein Straße 3a, 18059 Rostock, Germany

c Department of Chemistry and Food Chemistry, Technische Universität Dresden, Bergstraße 66, 01062 Dresden, Germany

Abstract

Correction for ‘Novel valdecoxib derivatives by ruthenium(II)-promoted 1,3-dipolar cycloaddition of nitrile oxides with alkynes – synthesis and COX-2 inhibition activity’ by Silvia Roscales et al., Med. Chem. Commun., 2018, DOI: 10.1039/c7md00575j.

About
Cited by
Related
Download options Please wait...

Associated articles

Article information

DOI
https://doi.org/10.1039/C8MD90011F
Article type
Correction
Submitted
01 Mar 2018
Accepted
01 Mar 2018
First published
07 Mar 2018
This article is Open Access
Creative Commons BY license

Med. Chem. Commun., 2018,9, 591-592

Permissions

Request permissions

Correction: Novel valdecoxib derivatives by ruthenium(II)-promoted 1,3-dipolar cycloaddition of nitrile oxides with alkynes – synthesis and COX-2 inhibition activity

S. Roscales, N. Bechmann, D. H. Weiss, M. Köckerling, J. Pietzsch and T. Kniess, Med. Chem. Commun., 2018, 9, 591 DOI: 10.1039/C8MD90011F

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements